{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T18:17:39Z","timestamp":1775585859459,"version":"3.50.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2010,5,14]],"date-time":"2010-05-14T00:00:00Z","timestamp":1273795200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1007\/s10157-010-0282-3","type":"journal-article","created":{"date-parts":[[2010,5,13]],"date-time":"2010-05-13T01:57:37Z","timestamp":1273715857000},"page":"372-376","source":"Crossref","is-referenced-by-count":13,"title":["Successful treatment of HCV-related cryoglobulinemic glomerulonephritis with double-filtration plasmapheresis and interferon combination therapy"],"prefix":"10.1007","volume":"14","author":[{"given":"Tomoko","family":"Namba","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rie","family":"Shiba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Hirai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuma","family":"Moriwaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Kadoya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanobu","family":"Takeji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukinori","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harumasa","family":"Yoshihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Yamauchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,5,14]]},"reference":[{"key":"282_CR1","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1038\/ki.1994.393","volume":"46","author":"RJ Johnson","year":"1994","unstructured":"Johnson RJ, Willson R, Yamabe H, Couser W, Alpers CE, Wener MH, et al. Renal manifestations of hepatitis\u00a0C virus infection. Kidney Int. 1994;46:1255\u201363.","journal-title":"Kidney Int"},{"key":"282_CR2","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0002-9343(99)00014-5","volume":"106","author":"L Dagestani","year":"1999","unstructured":"Dagestani L, Pomeroy C. Renal manifestations of hepatitis\u00a0C infection. Am J Med. 1999;106:347\u201354.","journal-title":"Am J Med"},{"key":"282_CR3","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/00004836-200108000-00009","volume":"33","author":"RA Willson","year":"2001","unstructured":"Willson RA. The benefit of long-term interferon-alfa therapy for symptomatic mixed cryoglobulinemia (cutaneous vasculitis\/membranoproliferative glomerulonephritis) associated with chronic hepatitis\u00a0C infection. J Clin Gastroenterol. 2001;33:137\u201340.","journal-title":"J Clin Gastroenterol"},{"key":"282_CR4","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1046\/j.1523-1755.1998.00113.x","volume":"54","author":"HP Pham","year":"1998","unstructured":"Pham HP, Feray C, Samuel D, Gigou M, Azoulay D, Paradis V, et al. Effects of ribavirin on hepatitis\u00a0C-associated nephrotic syndrome in four liver transplant recipient. Kidney Int. 1998;54:1311\u20139.","journal-title":"Kidney Int"},{"key":"282_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1053\/ajkd.2001.29291","volume":"38","author":"G Garini","year":"2001","unstructured":"Garini G, Allegri L, Carnevali L, Buzio C. Interferon-alpha in combination with ribavirin as initial treatment for hepatitis\u00a0C virus-associated cryoglobulinemic membranoproliferative glomerulonephritis. Am J Kidney Dis. 2001;38:1\u20135.","journal-title":"Am J Kidney Dis"},{"key":"282_CR6","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2215\/CJN.03710708","volume":"4","author":"N Perico","year":"2009","unstructured":"Perico N, et al. Hepatitis\u00a0C infection and chronic renal diseases. Clin J Am Soc Nephrol. 2009;4:207\u201320.","journal-title":"Clin J Am Soc Nephrol"},{"key":"282_CR7","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/j.1872-034X.2007.00117.x","volume":"37","author":"K Fujiwara","year":"2007","unstructured":"Fujiwara K, Kaneko S, Kakumu S, Sata M, Hige S, Tomita E, et al. Double filtration plasmapheresis and interferon combination therapy for chronic hepatitis\u00a0C patients with genotype 1 and high viral load. Hepatol Res. 2007;37:701\u201310.","journal-title":"Hepatol Res"},{"key":"282_CR8","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1002\/lt.21441","volume":"14","author":"Y Takada","year":"2008","unstructured":"Takada Y, Ito T, Ueda Y, Haga H, Egawa H, Tanaka K, et al. Effects of double-filtration plasmapheresis combined with interferon plus ribavirin for recurrent hepatitis\u00a0C after living donor liver transplantation. Liver Transplant. 2008;14:1044\u20137.","journal-title":"Liver Transplant"},{"key":"282_CR9","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1038\/ki.2008.85","volume":"73","author":"The Guideline Development Work Group and the Evidence Review Team","year":"2008","unstructured":"The Guideline Development Work Group and the Evidence Review Team. KDIGO clinical practice guidelines for the prevention, diagnosis, evaluation, and treatment of hepatitis\u00a0C in chronic kidney disease. Guideline 2: treatment of HCV infection in patients with CKD. Kidney Int. 2008;73:S20\u201345.","journal-title":"Kidney Int"},{"key":"282_CR10","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/sj.ki.5000142","volume":"69","author":"N Kamar","year":"2006","unstructured":"Kamar N, Rostaing L, Alric L. Treatment of hepatitis\u00a0C-virus-related glomerulonephritis. Kidney Int. 2006;69:436\u20139.","journal-title":"Kidney Int"},{"key":"282_CR11","first-page":"2151","volume":"89","author":"J Hayashi","year":"1994","unstructured":"Hayashi J, Ohmiya M, Kishihara Y, Tani Y, Kinukawa N, Ikematsu H, et al. A statistical analysis of predictive factors of response to human lymphoblastoid interferon in patients with chronic hepatitis\u00a0C. Am J Gastroenterol. 1994;89:2151\u20136.","journal-title":"Am J Gastroenterol"},{"key":"282_CR12","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0272-6386(00)70310-6","volume":"35","author":"F Fabrizi","year":"2000","unstructured":"Fabrizi F, Martin P, Dixit Y, Brezina M, Cole MJ, Vinson S, et al. Biological dynamics of viral load in hemodialysis patients with hepatitis\u00a0C virus. Am J Kidney Dis. 2000;35:122\u20139.","journal-title":"Am J Kidney Dis"},{"key":"282_CR13","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1016\/S0140-6736(99)02035-8","volume":"354","author":"B Ramratnam","year":"1999","unstructured":"Ramratnam B, Bonhoeffer S, Binley J, Hurley A, Zhang L, Mittler JE, et al. Rapid production and clearance of HIV-1 and hepatitis\u00a0C virus assessed by large volume plasma apheresis. Lancet. 1999;354:1782\u20135.","journal-title":"Lancet"},{"key":"282_CR14","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1046\/j.1365-2362.2001.00758.x","volume":"31","author":"V Schettler","year":"2001","unstructured":"Schettler V, Monazahian M, Wieland E, et al. Reduction of hepatitis\u00a0C virus load by H.E.L.P.-LDL apheresis. Eur J Clin Invest. 2001;31:154\u20135.","journal-title":"Eur J Clin Invest"},{"key":"282_CR15","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/jmv.20437","volume":"77","author":"HM Diepolder","year":"2005","unstructured":"Diepolder HM, Kashiwagi N, Teuber G, Ulsenheimer A, Franz M, Yokoyama T, et al. Leucocytapheresis with Adacolumn enhances HCV-specific proliferative responses in patients infected with hepatitis\u00a0C virus genotype 1. J Med Virol. 2005;77:209\u201315.","journal-title":"J Med Virol"},{"key":"282_CR16","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-2893.2005.00577.x","volume":"12","author":"K Sawada","year":"2005","unstructured":"Sawada K, Masaki N, Hayashi S, Zeniya M, Ishikawa T, Takahashi H, et al. Immunomodulatory effects of selective leucocytapheresis as a new adjunct to interferon-\u03b12b plus ribavirin combination therapy: a prospective study in patients with high plasma HCV viraemia. J Viral Hepat. 2005;12:274\u201382.","journal-title":"J Viral Hepat"},{"key":"282_CR17","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.hepres.2006.07.013","volume":"36","author":"T Yamashita","year":"2006","unstructured":"Yamashita T, Arai K, Sakai A, Mizukoshi E, Sakai Y, Kagaya T, et al. Virological effects and safety of combined double filtration plasmapheresis (DFPP) and interferon therapy in patients with chronic hepatitis\u00a0C: a preliminary study. Hepatol Res. 2006;36:167\u201375.","journal-title":"Hepatol Res"},{"key":"282_CR18","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1046\/j.1526-0968.2003.00030.x","volume":"7","author":"AA Kaplan","year":"2003","unstructured":"Kaplan AA. The use of apheresis in immune renal disorders. Ther Apher Dial. 2003;7:165\u201372.","journal-title":"Ther Apher Dial"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-010-0282-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10157-010-0282-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-010-0282-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T06:44:24Z","timestamp":1559112264000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10157-010-0282-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5,14]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["282"],"URL":"https:\/\/doi.org\/10.1007\/s10157-010-0282-3","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5,14]]}}}